3,3a-dehydropyrazidol has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies
| Studies (3,3a-dehydropyrazidol) | Trials (3,3a-dehydropyrazidol) | Recent Studies (post-2010) (3,3a-dehydropyrazidol) | Studies (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) | Trials (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) | Recent Studies (post-2010) (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 1,541 | 16 | 580 |
| Protein | Taxonomy | 3,3a-dehydropyrazidol (IC50) | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.13 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boland, A; Gérardy, J; Mossay, D; Seutin, V | 1 |
1 other study(ies) available for 3,3a-dehydropyrazidol and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death.
Topics: Animals; Antioxidants; Brain; Carbazoles; Cell Death; Cells, Cultured; Cerebral Cortex; Chromans; Drug Administration Schedule; Hippocampus; Intracellular Space; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Nitric Oxide; Peroxides; Rats; Rats, Wistar | 2003 |